Pre-procedural Anxiety Counseling in Patients Undergoing Coronary Angiography (PACE-CA)

Effect of Pre-procedural Counseling on Anxiety in Patients Undergoing Coronary Angiography

The goal of this quasi-experimental study is to assess the effect of preprocedural counselling on the anxiety in patients undergoing coronary angiography. It will include both genders with and without receiving preprocedural counselling. The main question[s] it aims to answer [is/are]:

  • Does pre-procedural counselling effect the anxiety levels among patients undergoing coronary angiography?
  • What is the current level of knowledge of patients regarding coronary angiography procedure?

Researchers will compare Interventional group in which patients will receive the structured counselling before procedure with Control group in which patients will not receive structured counselling to see whether counselling reduces the anxiety or not before procedure.

Participants will be asked to provide the following details;

  • Demographic questionnaire: Provide information regarding age, gender, marital status, educational level, and occupation.
  • Knowledge questionnaire: Complete a 20-item questionnaire assessing knowledge about the angiography procedure.
  • Anxiety assessment: Complete the 20-item Spielberger State Anxiety Inventory (STAI) to assess situational anxiety approximately 30 minutes before the procedure on the day of admission.

Study Overview

Detailed Description

Detailed Description

Coronary artery disease (CAD) is a major contributor to cardiovascular morbidity and mortality worldwide. Coronary angiography is an important diagnostic procedure used to evaluate coronary artery disease. However, uncertainty regarding the procedure, concerns about potential complications, and inadequate understanding of the procedural process may contribute to psychological distress before catheterization. Preprocedural anxiety may be accompanied by sympathetic nervous system activation, increased catecholamine release, elevated myocardial oxygen demand, and changes in physiological parameters. In some patients, anxiety may also contribute to procedural difficulties, including radial artery spasm.

Providing clear, structured information before coronary angiography may help patients develop realistic expectations, improve their understanding of the procedure, and cope more effectively with procedural anxiety. Nurse-led education is a non-pharmacological approach that can be incorporated into routine cardiac catheterization services. This study will evaluate this approach in the clinical setting of the Armed Forces Institute of Cardiology/National Institute of Heart Diseases (AFIC/NIHD), Rawalpindi, Pakistan.

Counselling Procedure

The educational intervention will be delivered individually by a cardiac catheterization nurse in a private room. The session will combine verbal explanations with a written information brochure to provide consistent information about the patient's preparation, the procedure itself, and recovery.

The educational content will include the following components:

  1. Preparation before the procedure

    Participants will receive explanations about the purpose of coronary angiography and the preparations required before catheterization. These will include fasting requirements, medication instructions as advised by the treating team, routine investigations, personal hygiene, and hospital gowning. The importance of following the clinical team's instructions will be emphasized.

  2. Information about the procedure

    The nurse will explain the main steps involved in coronary angiography, including the use of local anaesthesia, insertion of a catheter through the radial artery at the wrist or the femoral artery in the groin, and administration of contrast dye to visualize the coronary arteries. Participants will be informed that they generally remain awake during the procedure and may experience sensations such as warmth following contrast administration. The explanation will be intended to familiarize patients with the procedure and reduce uncertainty about what to expect.

  3. Care following the procedure

Counselling will cover postprocedural monitoring and recovery, including care of the arterial access site, movement restrictions when indicated, recommended fluid intake according to the clinical team's instructions, and avoidance of strenuous physical activity for the period advised by the treating team. General home-care and lifestyle guidance relevant to recovery will also be provided.

Assessment Procedures

Assessments will be conducted using standardized procedures in both study groups. The researcher-developed knowledge questionnaire will be used to assess patients' understanding of coronary angiography. Physiological measurements will be obtained using the same assessment procedures at the designated assessment points. State anxiety will be evaluated using the State scale of the State-Trait Anxiety Inventory (STAI-S).

The intervention group will undergo assessment before counselling and subsequent reassessment before catheterization. The control group will undergo corresponding assessments while receiving routine preprocedural care.

Grouping and Data Collection

The study will use individual matching to improve comparability between the intervention and control groups. Matching will be based on age, gender, and educational level. Participants will receive care according to their assigned study group, and information will be collected using the same assessment instruments and procedures across both groups.

The collected data will be used to examine differences in anxiety, patient knowledge, and physiological parameters between the groups. The findings may help inform the development of practical, nurse-led educational approaches for patients preparing to undergo coronary angiography.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Dr Javeria Kamran Dy Dir R&D dept, MBBS, MsPH
  • Phone Number: 92 51 9272654 92 3215502381
  • Email: javeriakamran@afic.gov.pk

Study Locations

    • Punjab Province
      • Rawalpindi, Punjab Province, Pakistan, 44000
        • Armed Institute of Cardiology,AFIC
        • Contact:
        • Principal Investigator:
          • Hamda Tayyab, BS in nursing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Planned for elective cardiac catheterization
  • Cognition intact/mentally alert

Exclusion Criteria:

  • Cardiopulmonary resuscitation before admission
  • Inability to provide written informed consent
  • Previous cardiac catheterization
  • Planned for primary PCI
  • Previously involved in cardiac rehabilitation program
  • Patients with history of antipsychotic drugs
  • Patients undergoing electrophysiological procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nurse-Led Pre-Procedural Educational Intervention

Participants will receive a 20-30-minute structured counseling session by a specialized nurse, including a written brochure and explanations about the procedure, post-procedure care, and home care.

Participants will receive a 20-30-minute individual educational counseling session delivered by a specialized cardiac catheterization nurse in a separate room. Knowledge will be assessed before counseling. The session will include written informational materials/brochures and explanations regarding the cardiac catheterization procedure, post-procedural care, and home care. Heart rate, systolic and diastolic blood pressure, respiratory rate, and anxiety levels using the STAI-S scale will be recorded at baseline and reassessed before catheterization. Post-counseling anxiety will be assessed by an independent research assistant blinded to group allocation.

No Intervention: Control Group: Patients receive routine pre-procedural care

Participants will attend a 10-15-minute session with a specialized cardiac catheterization nurse without structured educational counseling. Knowledge, physiological parameters, and anxiety levels will be assessed at baseline and reassessed before catheterization.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in State-Trait Anxiety Inventory-State (STAI-S)
Time Frame: At baseline score before counseling on the day the procedure is planned , and again on the day of coronary angiography before the procedure.

Change in anxiety levels measured using the State-Trait Anxiety Inventory-State (STAI-S) scale between baseline assessment before counseling and reassessment before coronary angiography. Scores will be compared between the intervention and control groups

At baseline score before counseling on the day the procedure is planned , and again on the day of coronary angiography before the procedure.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge Score
Time Frame: Baseline on the day the procedure is planned before Coronary Angiography

Knowledge scores assessed using the researcher-developed knowledge questionnaire and expressed as percentages, compared between the intervention and control groups.

Baseline on the day the procedure is planned before Coronary Angiography
Change in Heart Rate
Time Frame: Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure.

Change in heart rate measured in beats per minute (bpm) between baseline assessment and reassessment before coronary angiography.

Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure.
Change in Systolic Blood Pressure
Time Frame: Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure.

Systolic blood pressure will be measured in millimetres of mercury (mmHg)

Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure.
Change in Diastolic Blood Pressure
Time Frame: Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure

Diastolic Blood Pressure will be measured in millimetres of mercury (mmHg)

Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure
Change in Respiratory Rate
Time Frame: Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure

Respiratory rate will be measured in breaths per minute

Baseline on the day the procedure is planned and reassessment on the day of coronary angiography before the procedure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hamda Tayyab, BS in nursing, AFIC/NIHD

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 15, 2026

Primary Completion (Estimated)

May 15, 2027

Study Completion (Estimated)

May 15, 2027

Study Registration Dates

First Submitted

November 2, 2026

First Submitted That Met QC Criteria

November 13, 2026

First Posted (Actual)

November 17, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 13, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 9/2/R&D/2025/392

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared with other researchers under the current study plan. Study findings may be disseminated through scientific publications in aggregate form, while maintaining participant confidentiality.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe